ASX:AYAHealth Care Equipment & ServicesHealth Care Technology
ARTRYA ORD
$3.460
$0.190 (5.21%)
Day Range
$3.280 - $3.750
52 Week Range
$0.560 - $5.240
Volume
923.07K
Avg Volume (10D)
665.07K
Market Cap
$546.97M
Price Chart
Market Statistics
Open$3.680
Previous Close$3.650
Day High$3.750
Day Low$3.280
52 Week High$5.240
52 Week Low$0.560
Valuation
Market Cap546.97M
Shares Outstanding158.08M
Price to Book18.96
Trading Activity
Volume923.07K
Value Traded3.16M
Bid$3.730 × 3,230
Ask$3.200 × 1,235
Performance
1 Day0.85%
5 Day-15.64%
13 Week7.23%
52 Week293.37%
YTD-24.42%
Technical Indicators
RSI (14)35.76
50-Day SMA$3.940
200-Day SMA$2.236
Latest News
Biotechnology
Artrya Secures Second US Commercial Order for Salix SaaS Platform to Manage Coronary Artery Disease
Artrya (ASX: AYA) has signed a commercial agreement with US-based Northeast Georgia Health System for the use of its Salix AI cloud platform for point-of-care assessment and management of coronary artery disease.
1 min read
Biotechnology
Artrya Wins FDA Clearance to Advance Rollout of Salix Coronary Plaque Module
Artrya (ASX: AYA) has received clearance from the US Food and Drug Administration for its Salix Coronary Plaque module. The regulatory milestone enables the company to charge per-scan fees in its largest market, significantly enhancing revenue potential. The approval follows Artrya’s recent US launch and builds on momentum established with its Salix Coronary Anatomy platform. […]
3 min read
